AGIBOT Honored among 2024 Investment Community Healthcare VENTURE50

On January 9, 2025, the results of the 2024 VENTURE50 Awards, jointly sponsored by Zero2IPO Venture and Investment Community, were announced. AGIBOT was successfully selected as one of the healthcare VENTURE50 list due to its outstanding strength. This honour is not only a high recognition of AGIBOT, but also highlights its innovative ability and growth potential in the field of surgical robotics.

As an innovative explorer in China’s surgical robotics industry, AGIBOT has always focused on technological innovation in the field of intelligent surgical robots, continuously improving the competitiveness of its products, and is committed to promoting the widespread application and in-depth popularization of surgical robots in the field of healthcare, and contributing to the intelligent transformation of the medical field.

About VENTURE50

The VENTURE50 is an annual event aimed at identifying innovative companies with high growth potential in various industries, promoting efficient matchmaking between industry and capital, and contributing to the high-quality development of science and technology innovation. Since its inception in 2006, the VENTURE50 has gone through 18 years of development, and has become an important wind vane for investment in high-growth companies in China by virtue of its professional and rigorous selection mechanism.

As of December 2024, the competition has attracted a total of 79,000+ science and technology innovation enterprises to participate in the competition. The judging team consists of professionals from hundreds of first-tier investment institutions, and ensures the authority and fairness of the selection results by comprehensively evaluating the enterprises in terms of their growth, innovation, technological advantages, team qualities, operational capabilities, and other dimensions.